{"transactions":[{"id":887468,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":65129,"kind":"person","name":"Danahy Kevin Patrick","position":1,"cik":"0001913245","reported_name":"Danahy Kevin Patrick","relationship":{"officer":true,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2026-02-24T01:55:39.000Z","date":"2026-02-18","kind":"exercise","planned":true,"acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 14, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Options granted on September 23, 2022, to acquire up to 450,000 shares of Common Stock, in connection with reporting person's promotion, with 25% vesting on each anniversary of grant, pursuant to the terms of an amendment to reporting person's Employment Agreement dated February 9, 2022."}],"balance_after":300000,"derivative":{"exercise_price":1.53,"expiration_date":"2032-09-23","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001437749-26-005144","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1625101/000143774926005144/rdgdoc.xml","form_type":"4"}},{"id":887467,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":65129,"kind":"person","name":"Danahy Kevin Patrick","position":1,"cik":"0001913245","reported_name":"Danahy Kevin Patrick","relationship":{"officer":true,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-02-24T01:55:39.000Z","date":"2026-02-18","kind":"sale","planned":true,"acquired":false,"shares":5000,"price":23.64,"value":118200.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 14, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price in column 4 is the weighted average price per share sold. The price per share actually received by the reporting person ranged from $22.40 to $24.40 per share. For all transactions reported in this Form 4 using a weighted average price, the reporting person undertakes upon request by the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price within the range."}],"balance_after":43298,"source":{"system":"sec-edgar","filing":"0001437749-26-005144","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1625101/000143774926005144/rdgdoc.xml","form_type":"4"}},{"id":887466,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":65129,"kind":"person","name":"Danahy Kevin Patrick","position":1,"cik":"0001913245","reported_name":"Danahy Kevin Patrick","relationship":{"officer":true,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-02-24T01:55:39.000Z","date":"2026-02-18","kind":"exercise","planned":true,"acquired":true,"shares":5000,"price":1.53,"value":7650.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 14, 2025."}],"balance_after":48298,"source":{"system":"sec-edgar","filing":"0001437749-26-005144","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1625101/000143774926005144/rdgdoc.xml","form_type":"4"}},{"id":900331,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":65129,"kind":"person","name":"Danahy Kevin Patrick","position":1,"cik":"0001913245","reported_name":"Danahy Kevin Patrick","relationship":{"officer":true,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2026-02-18T01:47:42.000Z","date":"2026-02-17","kind":"exercise","planned":true,"acquired":false,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 14, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Options granted on September 23, 2022, to acquire up to 450,000 shares of Common Stock, in connection with reporting person's promotion, with 25% vesting on each anniversary of grant, pursuant to the terms of an amendment to reporting person's Employment Agreement dated February 9, 2022."}],"balance_after":305000,"derivative":{"exercise_price":1.53,"expiration_date":"2032-09-23","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001437749-26-004438","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1625101/000143774926004438/rdgdoc.xml","form_type":"4"}},{"id":900330,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":65129,"kind":"person","name":"Danahy Kevin Patrick","position":1,"cik":"0001913245","reported_name":"Danahy Kevin Patrick","relationship":{"officer":true,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2026-02-18T01:47:42.000Z","date":"2026-02-13","kind":"exercise","planned":true,"acquired":false,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 14, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Options granted on September 23, 2022, to acquire up to 450,000 shares of Common Stock, in connection with reporting person's promotion, with 25% vesting on each anniversary of grant, pursuant to the terms of an amendment to reporting person's Employment Agreement dated February 9, 2022."}],"balance_after":325000,"derivative":{"exercise_price":1.53,"expiration_date":"2032-09-23","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001437749-26-004438","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1625101/000143774926004438/rdgdoc.xml","form_type":"4"}},{"id":900329,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":65129,"kind":"person","name":"Danahy Kevin Patrick","position":1,"cik":"0001913245","reported_name":"Danahy Kevin Patrick","relationship":{"officer":true,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2026-02-18T01:47:42.000Z","date":"2026-02-12","kind":"exercise","planned":true,"acquired":false,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 14, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Options granted on September 23, 2022, to acquire up to 450,000 shares of Common Stock, in connection with reporting person's promotion, with 25% vesting on each anniversary of grant, pursuant to the terms of an amendment to reporting person's Employment Agreement dated February 9, 2022."}],"balance_after":345000,"derivative":{"exercise_price":1.53,"expiration_date":"2032-09-23","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001437749-26-004438","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1625101/000143774926004438/rdgdoc.xml","form_type":"4"}},{"id":900328,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":65129,"kind":"person","name":"Danahy Kevin Patrick","position":1,"cik":"0001913245","reported_name":"Danahy Kevin Patrick","relationship":{"officer":true,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-02-18T01:47:42.000Z","date":"2026-02-17","kind":"sale","planned":true,"acquired":false,"shares":20000,"price":23.63,"value":472600.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 14, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price in column 4 is the weighted average price per share sold. The price per share actually received by the reporting person ranged from $22.98 to $24.99 per share. For all transactions reported in this Form 4 using a weighted average price, the reporting person undertakes upon request by the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price within the range."}],"balance_after":43298,"source":{"system":"sec-edgar","filing":"0001437749-26-004438","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1625101/000143774926004438/rdgdoc.xml","form_type":"4"}},{"id":900327,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":65129,"kind":"person","name":"Danahy Kevin Patrick","position":1,"cik":"0001913245","reported_name":"Danahy Kevin Patrick","relationship":{"officer":true,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-02-18T01:47:42.000Z","date":"2026-02-17","kind":"exercise","planned":true,"acquired":true,"shares":20000,"price":1.53,"value":30600.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 14, 2025."}],"balance_after":63298,"source":{"system":"sec-edgar","filing":"0001437749-26-004438","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1625101/000143774926004438/rdgdoc.xml","form_type":"4"}},{"id":900326,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":65129,"kind":"person","name":"Danahy Kevin Patrick","position":1,"cik":"0001913245","reported_name":"Danahy Kevin Patrick","relationship":{"officer":true,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-02-18T01:47:42.000Z","date":"2026-02-13","kind":"sale","planned":true,"acquired":false,"shares":20000,"price":23.53,"value":470600.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 14, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price in column 4 is the weighted average price per share sold. The price per share actually received by the reporting person ranged from $23.00 to $25.00 per share. For all transactions reported in this Form 4 using a weighted average price, the reporting person undertakes upon request by the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price within the range."}],"balance_after":43298,"source":{"system":"sec-edgar","filing":"0001437749-26-004438","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1625101/000143774926004438/rdgdoc.xml","form_type":"4"}},{"id":900325,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":65129,"kind":"person","name":"Danahy Kevin Patrick","position":1,"cik":"0001913245","reported_name":"Danahy Kevin Patrick","relationship":{"officer":true,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-02-18T01:47:42.000Z","date":"2026-02-13","kind":"exercise","planned":true,"acquired":true,"shares":20000,"price":1.53,"value":30600.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 14, 2025."}],"balance_after":63298,"source":{"system":"sec-edgar","filing":"0001437749-26-004438","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1625101/000143774926004438/rdgdoc.xml","form_type":"4"}},{"id":900324,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":65129,"kind":"person","name":"Danahy Kevin Patrick","position":1,"cik":"0001913245","reported_name":"Danahy Kevin Patrick","relationship":{"officer":true,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-02-18T01:47:42.000Z","date":"2026-02-12","kind":"sale","planned":true,"acquired":false,"shares":20000,"price":23.37,"value":467400.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 14, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price in column 4 is the weighted average price per share sold. The price per share actually received by the reporting person ranged from $22.81 to $26.00 per share. For all transactions reported in this Form 4 using a weighted average price, the reporting person undertakes upon request by the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price within the range."}],"balance_after":43298,"source":{"system":"sec-edgar","filing":"0001437749-26-004438","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1625101/000143774926004438/rdgdoc.xml","form_type":"4"}},{"id":900323,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":65129,"kind":"person","name":"Danahy Kevin Patrick","position":1,"cik":"0001913245","reported_name":"Danahy Kevin Patrick","relationship":{"officer":true,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-02-18T01:47:42.000Z","date":"2026-02-12","kind":"exercise","planned":true,"acquired":true,"shares":20000,"price":1.53,"value":30600.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 14, 2025."}],"balance_after":63298,"source":{"system":"sec-edgar","filing":"0001437749-26-004438","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1625101/000143774926004438/rdgdoc.xml","form_type":"4"}},{"id":909509,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":65129,"kind":"person","name":"Danahy Kevin Patrick","position":1,"cik":"0001913245","reported_name":"Danahy Kevin Patrick","relationship":{"officer":true,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2026-02-12T00:46:34.000Z","date":"2026-02-11","kind":"exercise","planned":true,"acquired":false,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 14, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Options granted on September 23, 2022, to acquire up to 450,000 shares of Common Stock, in connection with reporting person's promotion, with 25% vesting on each anniversary of grant, pursuant to the terms of an amendment to reporting person's Employment Agreement dated February 9, 2022."}],"balance_after":365000,"derivative":{"exercise_price":1.53,"expiration_date":"2032-09-23","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001437749-26-003840","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1625101/000143774926003840/rdgdoc.xml","form_type":"4"}},{"id":909508,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":65129,"kind":"person","name":"Danahy Kevin Patrick","position":1,"cik":"0001913245","reported_name":"Danahy Kevin Patrick","relationship":{"officer":true,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2026-02-12T00:46:34.000Z","date":"2026-02-10","kind":"exercise","planned":true,"acquired":false,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 14, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Options granted on September 23, 2022, to acquire up to 450,000 shares of Common Stock, in connection with reporting person's promotion, with 25% vesting on each anniversary of grant, pursuant to the terms of an amendment to reporting person's Employment Agreement dated February 9, 2022."}],"balance_after":385000,"derivative":{"exercise_price":1.53,"expiration_date":"2032-09-23","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001437749-26-003840","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1625101/000143774926003840/rdgdoc.xml","form_type":"4"}},{"id":909507,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":65129,"kind":"person","name":"Danahy Kevin Patrick","position":1,"cik":"0001913245","reported_name":"Danahy Kevin Patrick","relationship":{"officer":true,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2026-02-12T00:46:34.000Z","date":"2026-02-09","kind":"exercise","planned":true,"acquired":false,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 14, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Options granted on September 23, 2022, to acquire up to 450,000 shares of Common Stock, in connection with reporting person's promotion, with 25% vesting on each anniversary of grant, pursuant to the terms of an amendment to reporting person's Employment Agreement dated February 9, 2022."}],"balance_after":405000,"derivative":{"exercise_price":1.53,"expiration_date":"2032-09-23","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001437749-26-003840","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1625101/000143774926003840/rdgdoc.xml","form_type":"4"}},{"id":909506,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":65129,"kind":"person","name":"Danahy Kevin Patrick","position":1,"cik":"0001913245","reported_name":"Danahy Kevin Patrick","relationship":{"officer":true,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-02-12T00:46:34.000Z","date":"2026-02-11","kind":"sale","planned":true,"acquired":false,"shares":20000,"price":25.2,"value":504000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 14, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price in column 4 is the weighted average price per share sold. The price per share actually received by the reporting person ranged from $23.36 to $26.36 per share. For all transactions reported in this Form 4 using a weighted average price, the reporting person undertakes upon request by the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price within the range."}],"balance_after":43298,"source":{"system":"sec-edgar","filing":"0001437749-26-003840","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1625101/000143774926003840/rdgdoc.xml","form_type":"4"}},{"id":909505,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":65129,"kind":"person","name":"Danahy Kevin Patrick","position":1,"cik":"0001913245","reported_name":"Danahy Kevin Patrick","relationship":{"officer":true,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-02-12T00:46:34.000Z","date":"2026-02-11","kind":"exercise","planned":true,"acquired":true,"shares":20000,"price":1.53,"value":30600.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 14, 2025."}],"balance_after":63298,"source":{"system":"sec-edgar","filing":"0001437749-26-003840","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1625101/000143774926003840/rdgdoc.xml","form_type":"4"}},{"id":909504,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":65129,"kind":"person","name":"Danahy Kevin Patrick","position":1,"cik":"0001913245","reported_name":"Danahy Kevin Patrick","relationship":{"officer":true,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-02-12T00:46:34.000Z","date":"2026-02-10","kind":"sale","planned":true,"acquired":false,"shares":20000,"price":23.52,"value":470400.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 14, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price in column 4 is the weighted average price per share sold. The price per share actually received by the reporting person ranged from $23.00 to $26.08 per share. For all transactions reported in this Form 4 using a weighted average price, the reporting person undertakes upon request by the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price within the range."}],"balance_after":43298,"source":{"system":"sec-edgar","filing":"0001437749-26-003840","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1625101/000143774926003840/rdgdoc.xml","form_type":"4"}},{"id":909503,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":65129,"kind":"person","name":"Danahy Kevin Patrick","position":1,"cik":"0001913245","reported_name":"Danahy Kevin Patrick","relationship":{"officer":true,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-02-12T00:46:34.000Z","date":"2026-02-10","kind":"exercise","planned":true,"acquired":true,"shares":20000,"price":1.53,"value":30600.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 14, 2025."}],"balance_after":63298,"source":{"system":"sec-edgar","filing":"0001437749-26-003840","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1625101/000143774926003840/rdgdoc.xml","form_type":"4"}},{"id":909502,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":65129,"kind":"person","name":"Danahy Kevin Patrick","position":1,"cik":"0001913245","reported_name":"Danahy Kevin Patrick","relationship":{"officer":true,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-02-12T00:46:34.000Z","date":"2026-02-09","kind":"sale","planned":true,"acquired":false,"shares":20000,"price":21.45,"value":429000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 14, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price in column 4 is the weighted average price per share sold. The price per share actually received by the reporting person ranged from $21.00 to $23.22 per share. For all transactions reported in this Form 4 using a weighted average price, the reporting person undertakes upon request by the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price within the range."}],"balance_after":43298,"source":{"system":"sec-edgar","filing":"0001437749-26-003840","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1625101/000143774926003840/rdgdoc.xml","form_type":"4"}},{"id":909501,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":65129,"kind":"person","name":"Danahy Kevin Patrick","position":1,"cik":"0001913245","reported_name":"Danahy Kevin Patrick","relationship":{"officer":true,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-02-12T00:46:34.000Z","date":"2026-02-09","kind":"exercise","planned":true,"acquired":true,"shares":20000,"price":1.53,"value":30600.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 14, 2025."}],"balance_after":63298,"source":{"system":"sec-edgar","filing":"0001437749-26-003840","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1625101/000143774926003840/rdgdoc.xml","form_type":"4"}},{"id":1021959,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":65129,"kind":"person","name":"Danahy Kevin Patrick","position":1,"cik":"0001913245","reported_name":"Danahy Kevin Patrick","relationship":{"officer":true,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2025-10-07T23:18:44.000Z","date":"2025-10-02","kind":"exercise","planned":true,"acquired":false,"shares":4600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 14, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Options granted on September 23, 2022, to acquire up to 450,000 shares of Common Stock, in connection with reporting person's promotion, with 25% vesting on each anniversary of grant, pursuant to the terms of an amendment to reporting person's Employment Agreement dated February 9, 2022."}],"balance_after":425000,"derivative":{"exercise_price":1.53,"expiration_date":"2032-09-23","underlying":"Common Stock","underlying_shares":4600},"source":{"system":"sec-edgar","filing":"0001437749-25-030665","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1625101/000143774925030665/rdgdoc.xml","form_type":"4"}},{"id":1021958,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":65129,"kind":"person","name":"Danahy Kevin Patrick","position":1,"cik":"0001913245","reported_name":"Danahy Kevin Patrick","relationship":{"officer":true,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-10-07T23:18:44.000Z","date":"2025-10-02","kind":"sale","planned":true,"acquired":false,"shares":4600,"price":18.53,"value":85238.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 14, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price in column 4 is the weighted average price per share sold. The price per share actually received by the reporting person ranged from $18.48 to $18.65 per share. For all transactions reported in this Form 4 using a weighted average price, the reporting person undertakes upon request by the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price within the range."}],"balance_after":43298,"source":{"system":"sec-edgar","filing":"0001437749-25-030665","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1625101/000143774925030665/rdgdoc.xml","form_type":"4"}},{"id":1021957,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":65129,"kind":"person","name":"Danahy Kevin Patrick","position":1,"cik":"0001913245","reported_name":"Danahy Kevin Patrick","relationship":{"officer":true,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-10-07T23:18:44.000Z","date":"2025-10-02","kind":"exercise","planned":true,"acquired":true,"shares":4600,"price":1.53,"value":7038.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 14, 2025."}],"balance_after":47898,"source":{"system":"sec-edgar","filing":"0001437749-25-030665","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1625101/000143774925030665/rdgdoc.xml","form_type":"4"}},{"id":1034202,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":65129,"kind":"person","name":"Danahy Kevin Patrick","position":1,"cik":"0001913245","reported_name":"Danahy Kevin Patrick","relationship":{"officer":true,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2025-09-23T01:24:41.000Z","date":"2025-09-19","kind":"exercise","planned":true,"acquired":false,"shares":400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 14, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Options granted on September 23, 2022, to acquire up to 450,000 shares of Common Stock, in connection with reporting person's promotion, with 25% vesting on each anniversary of grant, pursuant to the terms of an amendment to reporting person's Employment Agreement dated February 9, 2022."}],"balance_after":429600,"derivative":{"exercise_price":1.53,"expiration_date":"2032-09-23","underlying":"Common Stock","underlying_shares":400},"source":{"system":"sec-edgar","filing":"0001437749-25-029646","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1625101/000143774925029646/rdgdoc.xml","form_type":"4"}},{"id":1034201,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":65129,"kind":"person","name":"Danahy Kevin Patrick","position":1,"cik":"0001913245","reported_name":"Danahy Kevin Patrick","relationship":{"officer":true,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2025-09-23T01:24:41.000Z","date":"2025-09-18","kind":"exercise","planned":true,"acquired":false,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 14, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Options granted on September 23, 2022, to acquire up to 450,000 shares of Common Stock, in connection with reporting person's promotion, with 25% vesting on each anniversary of grant, pursuant to the terms of an amendment to reporting person's Employment Agreement dated February 9, 2022."}],"balance_after":430000,"derivative":{"exercise_price":1.53,"expiration_date":"2032-09-23","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001437749-25-029646","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1625101/000143774925029646/rdgdoc.xml","form_type":"4"}},{"id":1034200,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":65129,"kind":"person","name":"Danahy Kevin Patrick","position":1,"cik":"0001913245","reported_name":"Danahy Kevin Patrick","relationship":{"officer":true,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-09-23T01:24:41.000Z","date":"2025-09-19","kind":"sale","planned":true,"acquired":false,"shares":400,"price":18.48,"value":7392.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 14, 2025."}],"balance_after":43298,"source":{"system":"sec-edgar","filing":"0001437749-25-029646","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1625101/000143774925029646/rdgdoc.xml","form_type":"4"}},{"id":1034199,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":65129,"kind":"person","name":"Danahy Kevin Patrick","position":1,"cik":"0001913245","reported_name":"Danahy Kevin Patrick","relationship":{"officer":true,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-09-23T01:24:41.000Z","date":"2025-09-19","kind":"exercise","planned":true,"acquired":true,"shares":400,"price":1.53,"value":612.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 14, 2025."}],"balance_after":43698,"source":{"system":"sec-edgar","filing":"0001437749-25-029646","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1625101/000143774925029646/rdgdoc.xml","form_type":"4"}},{"id":1034198,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":65129,"kind":"person","name":"Danahy Kevin Patrick","position":1,"cik":"0001913245","reported_name":"Danahy Kevin Patrick","relationship":{"officer":true,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-09-23T01:24:41.000Z","date":"2025-09-18","kind":"sale","planned":true,"acquired":false,"shares":20000,"price":18.49,"value":369800.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 14, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price in column 4 is the weighted average price per share sold. The price per share actually received by the reporting person ranged from $18.48 to $19.48 per share. For all transactions reported in this Form 4 using a weighted average price, the reporting person undertakes upon request by the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price within the range."}],"balance_after":43298,"source":{"system":"sec-edgar","filing":"0001437749-25-029646","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1625101/000143774925029646/rdgdoc.xml","form_type":"4"}},{"id":1034197,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":65129,"kind":"person","name":"Danahy Kevin Patrick","position":1,"cik":"0001913245","reported_name":"Danahy Kevin Patrick","relationship":{"officer":true,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-09-23T01:24:41.000Z","date":"2025-09-18","kind":"exercise","planned":true,"acquired":true,"shares":20000,"price":1.53,"value":30600.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 14, 2025."}],"balance_after":63298,"source":{"system":"sec-edgar","filing":"0001437749-25-029646","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1625101/000143774925029646/rdgdoc.xml","form_type":"4"}},{"id":1457264,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":65129,"kind":"person","name":"Danahy Kevin Patrick","position":1,"cik":"0001913245","reported_name":"Danahy Kevin Patrick","relationship":{"officer":true,"officer_title":"Chief Commercial Officer"}}],"security":"Warrant (right to buy)","published_at":"2024-07-09T13:12:54.000Z","date":"2024-07-03","kind":"purchase","planned":false,"acquired":true,"shares":325,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The Reporting Person acquired the shares of common stock and the warrants pursuant to the exercise of subscription rights in connection with the Issuer's previously announced rights offering (the \"Rights Offering\"), as disclosed in the Registration Statement on Form S-3, as amended, and certain Current Reports on Form 8-K filed by the Issuer with the SEC."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person acquired the shares of common stock and the warrants pursuant to the exercise of subscription rights in connection with the Issuer's previously announced rights offering (the \"Rights Offering\"), as disclosed in the Registration Statement on Form S-3, as amended, and certain Current Reports on Form 8-K filed by the Issuer with the SEC."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the terms of the Rights Offering, the Reporting Person purchased units at a price of $10.00 per unit, with each unit consisting of one share of common stock and two warrants each to purchase one half share of common stock at an exercise price of $11.00 per whole share. The warrants differ only in their redemption provisions."}],"balance_after":325,"derivative":{"exercise_price":11,"exercise_date":"2024-07-03","expiration_date":"2029-07-03","underlying":"Common Stock","underlying_shares":325},"source":{"system":"sec-edgar","filing":"0001437749-24-022356","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1625101/000143774924022356/rdgdoc.xml","form_type":"4"}},{"id":1457263,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":65129,"kind":"person","name":"Danahy Kevin Patrick","position":1,"cik":"0001913245","reported_name":"Danahy Kevin Patrick","relationship":{"officer":true,"officer_title":"Chief Commercial Officer"}}],"security":"Warrant (right to buy)","published_at":"2024-07-09T13:12:54.000Z","date":"2024-07-03","kind":"purchase","planned":false,"acquired":true,"shares":325,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The Reporting Person acquired the shares of common stock and the warrants pursuant to the exercise of subscription rights in connection with the Issuer's previously announced rights offering (the \"Rights Offering\"), as disclosed in the Registration Statement on Form S-3, as amended, and certain Current Reports on Form 8-K filed by the Issuer with the SEC."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person acquired the shares of common stock and the warrants pursuant to the exercise of subscription rights in connection with the Issuer's previously announced rights offering (the \"Rights Offering\"), as disclosed in the Registration Statement on Form S-3, as amended, and certain Current Reports on Form 8-K filed by the Issuer with the SEC."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the terms of the Rights Offering, the Reporting Person purchased units at a price of $10.00 per unit, with each unit consisting of one share of common stock and two warrants each to purchase one half share of common stock at an exercise price of $11.00 per whole share. The warrants differ only in their redemption provisions."}],"balance_after":325,"derivative":{"exercise_price":11,"exercise_date":"2024-07-03","expiration_date":"2029-07-03","underlying":"Common Stock","underlying_shares":325},"source":{"system":"sec-edgar","filing":"0001437749-24-022356","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1625101/000143774924022356/rdgdoc.xml","form_type":"4"}},{"id":1457262,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":65129,"kind":"person","name":"Danahy Kevin Patrick","position":1,"cik":"0001913245","reported_name":"Danahy Kevin Patrick","relationship":{"officer":true,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2024-07-09T13:12:54.000Z","date":"2024-07-03","kind":"other","planned":false,"acquired":true,"shares":650,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The Reporting Person acquired the shares of common stock and the warrants pursuant to the exercise of subscription rights in connection with the Issuer's previously announced rights offering (the \"Rights Offering\"), as disclosed in the Registration Statement on Form S-3, as amended, and certain Current Reports on Form 8-K filed by the Issuer with the SEC."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the terms of the Rights Offering, the Reporting Person purchased units at a price of $10.00 per unit, with each unit consisting of one share of common stock and two warrants each to purchase one half share of common stock at an exercise price of $11.00 per whole share. The warrants differ only in their redemption provisions."}],"balance_after":36537,"source":{"system":"sec-edgar","filing":"0001437749-24-022356","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1625101/000143774924022356/rdgdoc.xml","form_type":"4"}},{"id":1736043,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":65129,"kind":"person","name":"Danahy Kevin Patrick","position":1,"cik":"0001913245","reported_name":"Danahy Kevin Patrick","relationship":{"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-11-17T14:11:44.000Z","date":"2023-11-16","kind":"purchase","planned":false,"acquired":true,"shares":12,"price":6.5,"value":78.0,"ownership":{"direct":true},"balance_after":35887,"source":{"system":"sec-edgar","filing":"0001437749-23-032410","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1625101/000143774923032410/rdgdoc.xml","form_type":"4"}},{"id":1736042,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":65129,"kind":"person","name":"Danahy Kevin Patrick","position":1,"cik":"0001913245","reported_name":"Danahy Kevin Patrick","relationship":{"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-11-17T14:11:44.000Z","date":"2023-11-16","kind":"purchase","planned":false,"acquired":true,"shares":600,"price":6.51,"value":3906.0,"ownership":{"direct":true},"balance_after":35875,"source":{"system":"sec-edgar","filing":"0001437749-23-032410","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1625101/000143774923032410/rdgdoc.xml","form_type":"4"}},{"id":1736041,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":65129,"kind":"person","name":"Danahy Kevin Patrick","position":1,"cik":"0001913245","reported_name":"Danahy Kevin Patrick","relationship":{"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-11-17T14:11:44.000Z","date":"2023-11-16","kind":"purchase","planned":false,"acquired":true,"shares":4781,"price":6.5199,"value":31171.6419,"ownership":{"direct":true},"balance_after":35275,"source":{"system":"sec-edgar","filing":"0001437749-23-032410","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1625101/000143774923032410/rdgdoc.xml","form_type":"4"}},{"id":1749347,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":65129,"kind":"person","name":"Danahy Kevin Patrick","position":1,"cik":"0001913245","reported_name":"Danahy Kevin Patrick","relationship":{"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2023-11-03T21:41:33.000Z","date":"2023-11-01","kind":"grant","planned":false,"acquired":true,"shares":460000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"100% vesting upon the earlier of (i) the six (6) year anniversary of the grant date, and (ii) the 1-year anniversary of a Company change of control."}],"balance_after":460000,"derivative":{"exercise_price":4.38,"expiration_date":"2033-11-01","underlying":"Common Stock","underlying_shares":460000},"source":{"system":"sec-edgar","filing":"0001437749-23-030250","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1625101/000143774923030250/rdgdoc.xml","form_type":"4"}},{"id":1749346,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":65129,"kind":"person","name":"Danahy Kevin Patrick","position":1,"cik":"0001913245","reported_name":"Danahy Kevin Patrick","relationship":{"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2023-11-03T21:41:33.000Z","date":"2023-11-01","kind":"other","planned":false,"acquired":false,"shares":130000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Reporting Person was erroneously granted an option to acquire 130,000 shares on October 23, 2023, which option was cancelled by mutual agreement on November 1, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares will vest in four equal annual installments on each of the first four annual anniversaries of the grant date, subject to the Reporting Person's continued service through each vesting date."}],"balance_after":0,"derivative":{"exercise_price":3.96,"expiration_date":"2033-10-23","underlying":"Common Stock","underlying_shares":130000},"source":{"system":"sec-edgar","filing":"0001437749-23-030250","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1625101/000143774923030250/rdgdoc.xml","form_type":"4"}},{"id":1749345,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":65129,"kind":"person","name":"Danahy Kevin Patrick","position":1,"cik":"0001913245","reported_name":"Danahy Kevin Patrick","relationship":{"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2023-11-03T21:41:33.000Z","date":"2023-10-23","kind":"grant","planned":false,"acquired":true,"shares":130000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares will vest in four equal annual installments on each of the first four annual anniversaries of the grant date, subject to the Reporting Person's continued service through each vesting date."}],"balance_after":130000,"derivative":{"exercise_price":3.96,"expiration_date":"2033-10-23","underlying":"Common Stock","underlying_shares":130000},"source":{"system":"sec-edgar","filing":"0001437749-23-030250","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1625101/000143774923030250/rdgdoc.xml","form_type":"4"}},{"id":1829384,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":65129,"kind":"person","name":"Danahy Kevin Patrick","position":1,"cik":"0001913245","reported_name":"Danahy Kevin Patrick","relationship":{"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2023-07-15T00:29:28.000Z","date":"2023-07-12","kind":"grant","planned":false,"acquired":true,"shares":200000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted on July 12, 2023 under the Issuer's 2017 Equity Incentive Plan. The shares subject to the option are subject to two tranches of performance-based vesting criteria tied to Issuer's market capitalization, with no vesting until the Issuer's market capitalization exceeds $4 billion, in both cases, subject to the Reporting Person's continued service through each vesting milestone."}],"balance_after":200000,"derivative":{"exercise_price":7.08,"expiration_date":"2033-07-12","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001437749-23-019993","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1625101/000143774923019993/rdgdoc.xml","form_type":"4"}},{"id":1907841,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":65129,"kind":"person","name":"Danahy Kevin Patrick","position":1,"cik":"0001913245","reported_name":"Danahy Kevin Patrick","relationship":{"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2023-05-03T01:45:36.000Z","date":"2023-04-29","kind":"grant","planned":false,"acquired":true,"shares":500000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted on April 29, 2023 under the Issuer's 2017 Equity Incentive Plan. The shares subject to the option are subject to four tranches of performance-based vesting criteria tied to Issuer's market capitalization, with no vesting until the Issuer's market capitalization exceeds $1 billion, in all cases, subject to the Reporting Person's continued service through each vesting milestone."}],"balance_after":500000,"derivative":{"exercise_price":6.44,"expiration_date":"2033-04-29","underlying":"Common Stock","underlying_shares":500000},"source":{"system":"sec-edgar","filing":"0001437749-23-012180","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1625101/000143774923012180/rdgdoc.xml","form_type":"4"}},{"id":1938938,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":65129,"kind":"person","name":"Danahy Kevin Patrick","position":1,"cik":"0001913245","reported_name":"Danahy Kevin Patrick","relationship":{"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2023-03-24T20:31:25.000Z","date":"2023-03-17","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"On February 14, 2022, the reporting person was granted an option to purchase 150,000 shares of the Issuer's common stock. The option vests upon the achievement of performance objectives, with vesting targets of 25% vesting per year upon achievement of said objectives established by the Issuer's Compensation Committee, subject to the reporting person's continued service through each vesting date. The performance objectives for 2022 were met, resulting in the vesting of the option as to 25,000 shares."}],"balance_after":25000,"derivative":{"exercise_price":6.41,"exercise_date":"2023-03-17","expiration_date":"2032-02-14","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001437749-23-007824","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1625101/000143774923007824/rdgdoc.xml","form_type":"4"}},{"id":2146955,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":65129,"kind":"person","name":"Danahy Kevin Patrick","position":1,"cik":"0001913245","reported_name":"Danahy Kevin Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-10-03T20:35:12.000Z","date":"2022-09-30","kind":"purchase","acquired":true,"shares":6500,"price":2.3,"value":14950.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This purchase price represents the weighted average purchase price of the shares purchased on September 30, 2022, ranging from $2.28 to $2.31 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4."}],"balance_after":6500,"source":{"system":"sec-edgar","filing":"0001839882-22-022698","document":"danahy-form4_093022.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1625101/000183988222022698/danahy-form4_093022.xml","form_type":"4"}},{"id":2150400,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":65129,"kind":"person","name":"Danahy Kevin Patrick","position":1,"cik":"0001913245","reported_name":"Danahy Kevin Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2022-09-27T21:46:40.000Z","date":"2022-09-23","kind":"grant","acquired":true,"shares":450000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted on September 23, 2022 under the Issuer's 2017 Equity Incentive Plan and pursuant to an amendment to the Reporting Person's employment agreement. The shares will vest in four equal annual installments on each of the first four annual anniversaries of the grant date, subject to the Reporting Person's continued service through each vesting date."}],"balance_after":450000,"derivative":{"exercise_price":1.53,"expiration_date":"2032-09-23","underlying":"Common Stock","underlying_shares":450000},"source":{"system":"sec-edgar","filing":"0001387131-22-010043","document":"danahy-form4_092722.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1625101/000138713122010043/danahy-form4_092722.xml","form_type":"4"}},{"id":2320797,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":65129,"kind":"person","name":"Danahy Kevin Patrick","position":1,"cik":"0001913245","reported_name":"Danahy Kevin Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Office"}}],"security":"Stock Option (right to buy)","published_at":"2022-03-22T20:11:33.000Z","date":"2022-02-14","kind":"grant","acquired":true,"shares":300000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted on February 14, 2022 under the Issuer's 2017 Inducement Equity Incentive Plan. The shares subject to the option are subject to a mix of time-based and performance-based vesting criteria. 200,000 shares will vest in equal annual installments over the following four years on the anniversary of the grant date and 100,000 shares will vest in two equal annual installments on the third and fourth anniversaries of the grant date, in all cases, subject to the Reporting Person's continued service through each vesting date."}],"balance_after":300000,"derivative":{"exercise_price":6.41,"expiration_date":"2032-02-14","underlying":"Common Stock","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0001104659-22-036559","document":"tm2210083-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1625101/000110465922036559/tm2210083-2_4seq1.xml","form_type":"4"}}]}